DE60238066D1 - Triazinderivate und deren verwendung als sonnenschutzmittel - Google Patents

Triazinderivate und deren verwendung als sonnenschutzmittel

Info

Publication number
DE60238066D1
DE60238066D1 DE60238066T DE60238066T DE60238066D1 DE 60238066 D1 DE60238066 D1 DE 60238066D1 DE 60238066 T DE60238066 T DE 60238066T DE 60238066 T DE60238066 T DE 60238066T DE 60238066 D1 DE60238066 D1 DE 60238066D1
Authority
DE
Germany
Prior art keywords
sub
alkyl
unsubstituted
substituted
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60238066T
Other languages
English (en)
Inventor
Barbara Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of DE60238066D1 publication Critical patent/DE60238066D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60238066T 2001-08-17 2002-08-08 Triazinderivate und deren verwendung als sonnenschutzmittel Expired - Lifetime DE60238066D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01810796 2001-08-17
CH16992001 2001-09-14
PCT/EP2002/008888 WO2003016289A1 (en) 2001-08-17 2002-08-08 Triazine derivatives and their use as sunscreens

Publications (1)

Publication Number Publication Date
DE60238066D1 true DE60238066D1 (de) 2010-12-02

Family

ID=25739004

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60238066T Expired - Lifetime DE60238066D1 (de) 2001-08-17 2002-08-08 Triazinderivate und deren verwendung als sonnenschutzmittel

Country Status (7)

Country Link
US (1) US7038046B2 (de)
EP (1) EP1423371B1 (de)
JP (1) JP4344241B2 (de)
AT (1) ATE485281T1 (de)
DE (1) DE60238066D1 (de)
DK (1) DK1423371T3 (de)
WO (1) WO2003016289A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7574545B2 (en) * 2000-10-16 2009-08-11 Electronics For Imaging, Inc. Method and apparatus for controlling a document output device with a control request stored at a server
US6748471B1 (en) * 2000-10-16 2004-06-08 Electronics For Imaging, Inc. Methods and apparatus for requesting and receiving a print job via a printer polling device associated with a printer
FR2867188A1 (fr) * 2004-03-03 2005-09-09 Oreal Derives de s-triazine possedant un groupement para-alcoxyphenyle et au moins un groupement aminobenzalmaloniques greffes ; compositions cosmetiques contenant ces derives; utilisations desdits derives de s-tri
US20070286827A1 (en) * 2006-06-12 2007-12-13 Esschem, Inc. Optical brighter and uv stabilizer for acrylic enhancements
WO2008003064A2 (en) * 2006-06-29 2008-01-03 Martek Biosciences Corporation Sweetened oil compositions and methods of making
WO2008022946A1 (en) * 2006-08-24 2008-02-28 Unilever Plc Photostable cosmetic compositions
US20080097070A1 (en) * 2006-10-19 2008-04-24 L'oreal Aqueous polyamine-containing systems for water-insoluble materials
US20080096782A1 (en) * 2006-10-19 2008-04-24 L'oreal Aqueous systems containing phospholipid, surfactant and phosphate ester for water-insoluble materials
US20120121515A1 (en) 2009-03-13 2012-05-17 Lenny Dang Methods and compositions for cell-proliferation-related disorders
ES2632954T3 (es) 2009-06-29 2017-09-18 Agios Pharmaceuticals, Inc. Derivados de quinolina-8-sulfonamida que tienen una actividad anticancerosa
WO2011050210A1 (en) 2009-10-21 2011-04-28 Agios Pharmaceuticals, Inc. Methods and compositions for cell-proliferation-related disorders
EP2568955A4 (de) 2010-05-10 2015-01-14 Segetis Inc Körperpflegeformulierungen mit alkylketalestern und herstellungsverfahren dafür
KR101856808B1 (ko) 2010-12-28 2018-05-10 닛산 가가쿠 고교 가부시키 가이샤 폴리이미드막 형성용 도포액, 액정 배향제, 폴리이미드막, 액정 배향막 및 액정 표시 소자
WO2012092546A2 (en) * 2010-12-30 2012-07-05 L'oreal S.A. Mascara compositions containing an oil-dispersible micronized wax and a water-dispersible wax
SG194697A1 (en) 2011-05-03 2013-12-30 Agios Pharmaceuticals Inc Pyruvate kinase activators for use in therapy
CN102827170A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN115536635A (zh) 2012-01-06 2022-12-30 法国施维雅药厂 治疗活性化合物及其使用方法
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
EP2906212A4 (de) 2012-10-15 2016-06-08 Agios Pharmaceuticals Inc Therapeutische verbindungen und zusammensetzungen
WO2015003360A2 (en) * 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
US9579324B2 (en) 2013-07-11 2017-02-28 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
EP3019480B1 (de) 2013-07-11 2020-05-06 Agios Pharmaceuticals, Inc. 2,4- oder 4,6-diaminopyrimidin-verbindungen als idh2-mutanten-inhibitoren für die behandlung von krebs
CN105492435B (zh) 2013-07-11 2018-06-29 安吉奥斯医药品有限公司 作为idh2突变体抑制剂的化合物
WO2015003355A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
US20150031627A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
KR20240010105A (ko) 2014-03-14 2024-01-23 아지오스 파마슈티컬스 아이엔씨. 치료적으로 활성인 화합물의 약제학적 조성물
US11234976B2 (en) 2015-06-11 2022-02-01 Agios Pharmaceuticals, Inc. Methods of using pyruvate kinase activators
US10653710B2 (en) 2015-10-15 2020-05-19 Agios Pharmaceuticals, Inc. Combination therapy for treating malignancies
CA3216701A1 (en) 2015-10-15 2017-04-20 Les Laboratoires Servier Combination therapy for treating malignancies
CN107827764A (zh) * 2017-11-27 2018-03-23 上海应用技术大学 一种双β‑氨基酮或双β‑氨基酯类的制备方法
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4105923A1 (de) 1991-02-26 1992-08-27 Basf Ag P-aminozimtsaeure-substituierte triazine
DE4223890A1 (de) * 1992-02-19 1993-08-26 Merck Patent Gmbh Triazin-derivate
FR2744721B1 (fr) 1996-02-12 1999-06-18 Oreal Nouveaux derives insolubles de s-triazine, leur procede de preparation, compositions les contenant et leurs utilisations

Also Published As

Publication number Publication date
US7038046B2 (en) 2006-05-02
EP1423371A1 (de) 2004-06-02
JP2005501855A (ja) 2005-01-20
WO2003016289A1 (en) 2003-02-27
JP4344241B2 (ja) 2009-10-14
US20040242579A1 (en) 2004-12-02
ATE485281T1 (de) 2010-11-15
DK1423371T3 (da) 2011-02-07
EP1423371B1 (de) 2010-10-20

Similar Documents

Publication Publication Date Title
DE60238066D1 (de) Triazinderivate und deren verwendung als sonnenschutzmittel
HUP0203841A2 (en) 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them
JP2005538072A5 (de)
DK0671161T3 (da) Ectoin og ectoinderivater som fugtighedsgiver i kosmetikprodukter
HUP0300641A2 (hu) Triazaspiro[5.5]undekán-származékok és hatóanyagként ezeket tartalmazó gyógyszerkészítmények
BR9908764A (pt) Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica
TR200200099T2 (tr) Th2 farklılaşma inhibitörleri
AR036107A1 (es) Derivados de 6-fenilpirrolpirimidindiona, antagonista de los receptores a2 de la adenosina, particularmente del subtipo a2, de aplicacion en la prevencion de la degranulacion de los mastocitos; composiciones farmaceuticas formuladas con dichos compuestos y uso de los mismos en la preparacion de medi
HUP0004259A2 (hu) VLA-4 által mediált leukocita adhéziót gátló szubsztituált fenilalanin-származékok, ezeket tartalmazó gyógyászati készítmények
HUP0402352A2 (hu) Foszfodiészteráz (PDE) 7 inhibitorként alkalmazható pirimidinszármazékok és ezeket tartalmazó gyógyszerkészítmények
ATE174917T1 (de) Pyrazolo(1,5-a>pyrimidinderivate und sie enthaltende antiinflammatorische mittel
CY1108652T1 (el) Παραγωγα μορφολινυλ-ουριας για χρηση στη θεραπεια φλεγμονωδων ασθενειων
CY1106714T1 (el) Παραγωγα αλκυλικων αιθερων ή τα αλατα τους
AR016762A1 (es) Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo
JP2005501855A5 (de)
HUP0400757A2 (hu) Protein kináz gátló hatású kondenzált pirazolszármazékok és ezeket tartalmazó gyógyszerkészítmények
HUP0004531A2 (hu) VLA-4 által mediált leukocita adhéziót gátló 4-aminofenilalanin-vegyületek, ezeket tartalmazó gyógyászati készítmények, valamint alkalmazásuk
BR0010716A (pt) Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas
AR030424A1 (es) Derivados de 6-fenilpirrol[3,2-d] pirimidina y de 6-fenilpirrol[2,3-d]-pirimidin-2,4-diona; procedimientos de preparacion de dichos derivados; compuestos intermediarios de aplicacion en la preparacion de dichos derivados y el uso de los mismos en el tratamiento del cuerpo humano y/o de animales y/o
HUP0301032A2 (hu) Ciklin-dependens kinázok N-{5-[(5-alkil-2-oxazolil)-metil-tio]-2-tiazolil}-karboxamid inhibitorai, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
ES2104952T3 (es) Derivados de nitroanilina y su uso como agentes antitumorales.
AR024904A1 (es) Derivados de pirrol heteroaril sustituidos, su preparacion y sus usos terapeuticos.
HUP0301030A2 (hu) Kardiális aritmiák kezelésére alkalmazható új aza-biciklooktán-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
EP0321968A3 (en) Compounds active on the cardiovascular system
DK1095040T3 (da) Hidtil ukendte benzoxazoler med PDE-inhiberende aktivitet